内皮抑素(ES)多克隆抗体
Polyclonal Antibody to Endostatin (ES)
- 编号PAA542Hu06
- 物种Homo sapiens (Human，人)相同的名称，不同的物种。
- 来源多抗制备
- 宿主兔
- 效价-
- Ig类型IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原EPA542Hu61-内皮抑素(ES)真核蛋白
- 缓冲液成份0.01M 磷酸盐缓冲液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性状液体
- 浓度500µg/mL
- 且适物种-
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术，请参见流式抗体。 - 下载英文说明书 中文说明书
- 规格20µl100µl200µl1ml10ml
- 价格¥ 623¥ 1453¥ 2076¥ 5190¥ 20760
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
产品包装(模拟)
产品包装(模拟)
Used in DAB staining on fromalin fixed paraffin- embedded kidney tissue
Figure. Western Blot; Sample: Recombinant ES, Human.
通过ISO 9001、ISO 13485质量体系认证
特异性
该抗体是针对ES的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别ES。
用法
Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
赠品
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| APA542Hu61 | 内皮抑素(ES)活性蛋白 | Cell culture; Activity Assays. |
| EPA542Hu61 | 内皮抑素(ES)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| CPA542Hu31 | 内皮抑素(ES)钥孔血蓝蛋白偶联物 | Immunogen; SDS-PAGE; WB. |
| PAA542Hu01 | 内皮抑素(ES)多克隆抗体 | WB; IHC; ICC; IP. |
| PAA542Hu06 | 内皮抑素(ES)多克隆抗体 | WB; IHC; ICC; IP. |
| WEA542Hu | 内皮抑素(ES)检测试剂盒(酶联免疫吸附试验法,宽范围) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEA542Hu | 内皮抑素(ES)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| CEA542Hu | 内皮抑素(ES)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA542Hu | 内皮抑素(ES)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
| KSA542Hu11 | 内皮抑素(ES)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". |
参考文献
| 杂志 | 参考文献 |
| Cancer Immunology | Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice[SpringerLink: u38777121t6660l5] |
| Journal of Fluoresence | Erythrocyte Protoporphyrin Fluorescence as a Biomarker for Monitoring Antiangiogenic Cancer Therapy[SpringerLink: 4v306130302257w0] |
| The Journal of Gene Medicine | Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma[Wiley: source] |
| Biomedicine & Pharmacotherapy | Endostatin neoadjuvant gene therapy extends survival in an orthotopic metastatic mouse model of renal cell carcinoma[ScienceDirect: S075333221100151X] |
| Science Alert | Antiangiogenic Activities of Cinnamon, Black and Green Tea Extracts on Experimentally Induced Breast Cancer in Rats[Scialert: Source] |
| The Journal of Immunology | Inflammation Induced by MMP-9 Enhances Tumor Regression of Experimental Breast Cancer[PubMed: PMC3619527] |
| Prostaglandins & Other Lipid Mediators | Promotion of adipogenesis by an EP2 receptor agonist via stimulation of angiogenesis in pulmonary emphysema[Pubmed:24911647] |
| American Journal of Physiology - Heart and Circulatory Physiology | Endostatin and kidney fibrosis in aging: a case for antagonistic pleiotropy?[Source] |
| shock | Angiogenesis inhibitor endostatin protects mice with sepsis from multiple organ dysfunction syndrome[PubMed: 26125086] |
| Clin Rev Allergy Immunol | Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature[PubMed: 26142066] |
| Angiologia e Cirurgia Vascular | Peripheral vasculopathy in Raynaud phenomenon: Vascular disease biomarkers[science:S1646706X16300052] |
| Clinical Rheumatology | Impaired angiogenesis as a feature of digital ulcers in systemic sclerosis[Pubmed:26920752] |
| Blood biomarker for early blood brain barrier disruption in ischemic stroke[patent:US20170199205A1] |